Literature DB >> 21832017

Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses.

Mariette F Ducatez1, Zhipeng Cai, Malik Peiris, Yi Guan, Zhiping Ye, Xiu-Feng Wan, Richard J Webby.   

Abstract

Highly pathogenic H5N1 avian influenza viruses emerged in 1996 and have since evolved so extensively that a single strain can no longer be used as a prepandemic vaccine or diagnostic reagent. We therefore sought to identify the H5N1 strains that may best serve as cross-reactive diagnostic reagents. We compared the cross-reactivity of 27 viruses of clades 0, 1, 2.1, 2.2, 2.3, and 4 and of four computationally designed ancestral H5N1 strains by hemagglutination inhibition (HI) and microneutralization (MN) assays. Antigenic cartography was used to analyze the large quantity of resulting data. Cartographs of HI titers with chicken red blood cells were similar to those of MN titers, but HI with horse red blood cells decreased antigenic distances among the H5N1 strains studied. Thus, HI with horse red blood cells seems to be the assay of choice for H5N1 diagnostics. Whereas clade 2.2 antigens were able to detect antibodies raised to most of the tested H5N1 viruses (and clade 2.2-specific antisera detected most of the H5N1 antigens), ancestral strain A exhibited the widest reactivity pattern and hence was the best candidate diagnostic reagent for broad detection of H5N1 strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832017      PMCID: PMC3187336          DOI: 10.1128/JCM.01279-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

Authors:  Isabel Leroux-Roels; Astrid Borkowski; Thomas Vanwolleghem; Mamadou Dramé; Frédéric Clement; Eliane Hons; Jeanne-Marie Devaster; Geert Leroux-Roels
Journal:  Lancet       Date:  2007-08-18       Impact factor: 79.321

2.  Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007.

Authors:  Wai Lan Wu; Yixin Chen; Pui Wang; Wenjun Song; Siu-Ying Lau; Jane M Rayner; Gavin J D Smith; Robert G Webster; J S Malik Peiris; Tianwei Lin; Ningshao Xia; Yi Guan; Honglin Chen
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

3.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

Authors:  Elena A Govorkova; Richard J Webby; Jennifer Humberd; Jon P Seiler; Robert G Webster
Journal:  J Infect Dis       Date:  2006-06-09       Impact factor: 5.226

5.  Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

Authors:  Iain Stephenson; Roberto Bugarini; Karl G Nicholson; Audino Podda; John M Wood; Maria C Zambon; Jacqueline M Katz
Journal:  J Infect Dis       Date:  2005-03-14       Impact factor: 5.226

6.  Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses.

Authors:  Qingbing Zheng; Lin Xia; Wai Lan Wu; Zhenhua Zheng; Yongting Huo; Jun Wu; Yanning Liu; Hai Yu; Yixin Chen; Siu-Ying Lau; Honglin Chen; Wenxin Luo; Ningshao Xia
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

7.  Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

Authors:  Kanta Subbarao; Hualan Chen; David Swayne; Louise Mingay; Ervin Fodor; George Brownlee; Xiyan Xu; Xiuhua Lu; Jacqueline Katz; Nancy Cox; Yumiko Matsuoka
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

8.  Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine.

Authors:  I Stephenson; J M Wood; K G Nicholson; A Charlett; M C Zambon
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

9.  Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine.

Authors:  Isabel Leroux-Roels; Roger Bernhard; Pascal Gérard; Mamadou Dramé; Emmanuel Hanon; Geert Leroux-Roels
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

10.  Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.

Authors:  Benoît Baras; Koert J Stittelaar; James H Simon; Robert J M M Thoolen; Sally P Mossman; Frank H M Pistoor; Geert van Amerongen; Martine A Wettendorff; Emmanuel Hanon; Albert D M E Osterhaus
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

View more
  13 in total

1.  AntigenMap 3D: an online antigenic cartography resource.

Authors:  J Lamar Barnett; Jialiang Yang; Zhipeng Cai; Tong Zhang; Xiu-Feng Wan
Journal:  Bioinformatics       Date:  2012-03-06       Impact factor: 6.937

2.  Contact between bird species of different lifespans can promote the emergence of highly pathogenic avian influenza strains.

Authors:  Paul S Wikramaratna; Oliver G Pybus; Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

3.  Identifying antigenicity-associated sites in highly pathogenic H5N1 influenza virus hemagglutinin by using sparse learning.

Authors:  Zhipeng Cai; Mariette F Ducatez; Jialiang Yang; Tong Zhang; Li-Ping Long; Adrianus C Boon; Richard J Webby; Xiu-Feng Wan
Journal:  J Mol Biol       Date:  2012-05-17       Impact factor: 5.469

4.  Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1.

Authors:  Inna G Ovsyannikova; Sarah J White; Randy A Albrecht; Adolfo García-Sastre; Gregory A Poland
Journal:  Viral Immunol       Date:  2014-04-30       Impact factor: 2.257

5.  Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China.

Authors:  Xiu-Feng Wan; Libo Dong; Yu Lan; Li-Ping Long; Cuiling Xu; Shumei Zou; Zi Li; Leying Wen; Zhipeng Cai; Wei Wang; Xiaodan Li; Fan Yuan; Hongtao Sui; Ye Zhang; Jie Dong; Shanhua Sun; Yan Gao; Min Wang; Tian Bai; Lei Yang; Dexin Li; Weizhong Yang; Hongjie Yu; Shiwen Wang; Zijian Feng; Yu Wang; Yuanji Guo; Richard J Webby; Yuelong Shu
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

6.  Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.

Authors:  Corey J Crevar; Donald M Carter; Kevin Y J Lee; Ted M Ross
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Antigenic and genetic evolution of low-pathogenicity avian influenza viruses of subtype H7N3 following heterologous vaccination.

Authors:  Maria Serena Beato; Yifei Xu; Li-Ping Long; Ilaria Capua; Xiu-Feng Wan
Journal:  Clin Vaccine Immunol       Date:  2014-02-19

8.  Antigenic characterization of recent H5N1 highly pathogenic avian influenza viruses circulating in Egyptian poultry.

Authors:  Maria Serena Beato; Marzia Mancin; Jialiang Yang; Alessandra Buratin; Marco Ruffa; Silvia Maniero; Alice Fusaro; Calogero Terregino; Xiu-Feng Wan; Ilaria Capua
Journal:  Virology       Date:  2012-11-02       Impact factor: 3.616

9.  Antigenic characterization of H3N2 influenza A viruses from Ohio agricultural fairs.

Authors:  Zhixin Feng; Janet Gomez; Andrew S Bowman; Jianqiang Ye; Li-Ping Long; Sarah W Nelson; Jialiang Yang; Brigitte Martin; Kun Jia; Jacqueline M Nolting; Fred Cunningham; Carol Cardona; Jianqiang Zhang; Kyoung-Jin Yoon; Richard D Slemons; Xiu-Feng Wan
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

10.  Effect of a straw-derived xylooligosaccharide on broiler growth performance, endocrine metabolism, and immune response.

Authors:  Sun Zhenping; Lv Wenting; Yu Ruikui; Li Jia; Liu Honghong; Sun Wei; Wang Zhongmie; Li Jingpan; Shan Zhe; Qin Yuling
Journal:  Can J Vet Res       Date:  2013-04       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.